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Abstract: Final lesion volume (FLV) is a surrogate outcome measure in anterior circulation stroke 
(ACS). In posterior circulation stroke (PCS), this relation is plausibly understudied due to a lack of 
methods that automatically quantify FLV. The applicability of deep learning approaches to PCS is 
limited due to its lower incidence compared to ACS. We evaluated strategies to develop a convolu-
tional neural network (CNN) for PCS lesion segmentation by using image data from both ACS and 
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PCS patients. We included follow-up non-contrast computed tomography scans of 1018 patients 
with ACS and 107 patients with PCS. To assess whether an ACS lesion segmentation generalizes to 
PCS, a CNN was trained on ACS data (ACS-CNN). Second, to evaluate the performance of only 
including PCS patients, a CNN was trained on PCS data. Third, to evaluate the performance when 
combining the datasets, a CNN was trained on both datasets. Finally, to evaluate the performance 
of transfer learning, the ACS-CNN was fine-tuned using PCS patients. The transfer learning strategy 
outperformed the other strategies in volume agreement with an intra-class correlation of 0.88 
(95%CI: 0.83–0.92) vs. 0.55 to 0.83 and a lesion detection rate of 87% vs. 41–77 for the other strategies. 
Hence, transfer learning improved the FLV quantification and detection rate of PCS lesions com-
pared to the other strategies. 
Keywords: posterior stroke; segmentation; transfer learning; deep learning; CT 
 
1. Introduction 
Infarct volume, representing the tissue damage after an acute ischemic stroke (AIS), 
is commonly considered as a surrogate endpoint for the primary functional outcome 
(modified Rankin Scale (mRS) after 90 days) [1]. Various trials have shown a strong asso-
ciation of final lesion volume (FLV) with functional outcome in patients suffering from a 
stroke due to a large vessel occlusion in the anterior circulation [1,2]. 
However, in patients with a stroke due to a posterior circulation stroke (PCS), the 
relation between FLV and outcome is understudied [3]. The low number of studies ad-
dressing this relation may be due to the combination of two reasons; the relatively low 
prevalence of PCS compared to anterior circulation stroke (ACS) and the lack of auto-
mated analysis of PCS lesion volume assessment. 
With the huge effectiveness of endovascular treatment of anterior circulation stroke 
patients, treatment of posterior stroke has attained renewed interest in various studies 
and trials. For example, the recently completed BASICS trial [4] could not show a benefi-
cial effect of endovascular treatment with functional outcome used as an outcome meas-
ure. Alternatively, secondary outcome measures such as FLV might show a beneficial ef-
fect of certain treatments since functional outcome, as addressed by the mRS, is a rather 
coarse outcome measure, which is also affected by many other confounders [5]. Develop-
ing methods that automatically segment lesions due to a posterior circulation stroke (PCS) 
would help investigate FLV as a surrogate outcome for this type of stroke. 
Solutions for the automatic segmentation of FLV based on convolutional neural net-
works (CNNs) have been presented in the literature for CT and MR imaging [6,7]. How-
ever, these studies have only considered the FLV of patients with an AIS due to an occlu-
sion of the anterior circulation [1,6]. To achieve good performance, CNNs typically require 
large amounts of labeled training data. However, PCS constitutes only 26% of AIS cases 
[8,9], and thus, training of CNNs for automatic PCS lesion segmentation is hindered by 
the limited availability of data. Furthermore, the applicability of methods developed for 
ACS FLV segmentation on posterior stroke lesion segmentation is unknown. 
Several methods exist for dealing with a lack of data to train a CNN. One method 
that reduces the data needed to train CNNs by reusing knowledge is transfer learning 
[10]. To perform transfer learning, a CNN is pre-trained on a task for which large amounts 
of image data are available and fine-tuned on a different task for which little image data 
are available. Transfer learning has been successfully applied to solve various medical 
image analysis problems [11–14]. 
We evaluate strategies to create automated PCS lesion segmentation by using image 
data from patients with ACS and patients with PCS. We hypothesize that transfer learning 
utilizing data of ACS lesions improves automatic PCS lesion segmentation performance 
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compared to alternative strategies: training a CNN on only ACS lesions, only on PCS le-
sions, or on the combination of ACS and PCS lesions. 
2. Materials and Methods 
2.1. Patient and Image Data 
All involved patients in this retrospective study or their legal representatives pro-
vided written informed consent. The medical ethics committee of each participating hos-
pital approved the use of the data after anonymization. 
The Hermes dataset consists of 1665 patients who suffered from an ACS and was 
obtained from the HERMES collaboration [15], which investigated the effectiveness of 
endovascular therapy for treating ACS. This collaboration combined data from seven clin-
ical randomized trials and collected data between December 2010 and December 2014. 
The scans contain a varying number of slices, which each have 512 rows and columns. The 
inclusion criteria are shown in Figure A1A. Patients were excluded if no follow-up non-
contrast computed tomography (FU-NCCT) was made in the time window between 12 h 
and 2 weeks after stroke onset or if the preprocessing steps were unsuccessful. In total, 
1018 patients out of the 1665 patients were included. Baseline characteristics of the in-
cluded patients are shown in Table 1.  
The BASICS dataset consists of 168 patients who suffered from a PCS and was ob-
tained from the BASICS trial [16,17], which investigated the effectiveness of endovascular 
therapy for treating patients with a PCS. This trial included patients from 23 centers, and 
the data were collected between 2011 and 2019. The scans are composed of a varying num-
ber of slices that each have 512 rows and columns. Imaging parameters are shown in Table 
A1. Inclusion criteria for our study are shown in Figure A1B. 
Infarcts evolve over time, and the most recent FU-NCCT scans imaged the most 
evolved infarcts with the lowest densities. As a result of the more distinct presence of the 
infarcts in later scans, these scans are commonly used for the infarct volume assessment 
in clinical practice and clinical research. Hence, the latest FU-NCCT scan was used if mul-
tiple scans were available for the same patient. Patients were excluded if no FU-NCCT 
was made or if the follow-up image was of insufficient quality. 
In total, 107 patients out of the 168 available patients were included. The mean and 
median time between symptom onset and the most recent follow-up NCCT are respec-
tively, 98.5 h and 28 (IQR: 24–32). Baseline characteristics of the included BASICS patients 
are shown in Table 1. The infarcted regions, as expressed in affected PC-ASPECTS regions, 
are shown in Table A2 in the appendix. 
Table 1. Baseline characteristics, treatment and time data for patients with posterior circulation stroke and anterior circu-
lation stroke. Prior to posterior stroke, transient ischemic attack (TIA), posterior circulation TIA, and atrial fibrillation 
(history or 12 lead electrocardiogram (ECG)) were not available (NAV) for the HERMES dataset. We use abbreviations for 
the National Institutes of Health Stroke Scale (NIHSS), modified Ranking Scale (mRS) and, Intravenous Thrombolysis 
(IVT). 
Parameter Posterior Stroke Anterior Stroke 
Clinical   
Age, years, mean (Standard Deviation) 65.65 (12.2) 66.1 (13.3) 
Sex, F, No. [%] 34/107 [31.8] 458/1018 [45] 
NIHSS at baseline, mean [median] (N) 21.4 [19] (107) 17 [17] (1015) 
Prior Conditions   
Diabetes mellitus, No. [%] 28/107 [26.2] 169/1018 [16.6] 
Hypertension, No. [%] 64/107 [59.8] 564/1018 [55.4] 
Stroke, No. [%] 21/107 [19.6] 121/1018 [11.9] 
Posterior circulation stroke, No. [%] 7/107 [6.5] NAV 
TIA, No. [%] 10/106 [9.4] NAV 
Posterior circulation TIA, No. [%] 2/106 [1.9] NAV 
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Atrial fibrillation, No. [%] 13/107 [12.1] 314/1018 [30.8] 
Atrial fibrillation (history or 12 lead ECG), No. [%] 23/107 [21.5] NAV 
Pre-Stroke mRS   
0, No. [%] 80/107 [74.8] 836/1017 [82.1] 
1, No. [%] 11/107[10.3] 129/1017 [12.7] 
2, No. [%] 13/107 [12.1] 29/1017 [2.9] 
3, No. [%] 3/107[2.8] 23/1017 [2.3] 
Treatment   
IVT, No. [%] 92/107 [86] 872/1018 [85.7] 
Time   
Stroke onset to IVT, min., mean [Standard Deviation] (N) 176.9 [176.102] (90) 112.2 [57.2] (871) 
2.2. Reference Segmentations 
For patients with an ACS, reference segmentations were obtained by manual anno-
tation by one of two experienced observers on the most recent FU-NCCT. The annotation 
procedure is outlined in [1]. In summary, a window width of 30 Hounsfield Units (HU) 
and a center level of 35 HU was set in ITK-Snap [18]. All hypo-dense regions on the ipsi-
lateral hemisphere including edema were included in the segmentations. Infarcted tissue 
in the ipsilateral hemisphere with signs of an old infarct were excluded from the reference 
segmentations. Parenchymal hemorrhages adjacent to or within the affected area were 
included in the reference segmentations. Finally, reference segmentations were checked 
and, if necessary, corrected by one of three radiologists, each of whom had more than 5 
years of experience. 
Reference segmentations of lesions caused by a PCS on FU-NCCT scans were manu-
ally created by a single trained observer (IVO) and were checked by an experienced radi-
ologist (CBLMM) who has more than 15 years of experience. Lesions were segmented by 
using the aforementioned window width and center level using ITK-Snap software [18]. 
PC-ASPECTS scores [19], which were scored by two experienced radiologists, were used 
when available to identify the infarcted territory. 
2.3. Preprocessing 
The intracranial region as a volume of interest was obtained automatically using a 
combination of preprocessing steps [6]. The bone was segmented using a threshold-based 
segmentation by selecting all voxels with an intensity of 170 HU or higher. Subsequently, 
the foramina, except the foramen magnum, were closed using morphological filters, and 
a region-growing algorithm was applied to select the intracranial volume. To obtain the 
final volume of interest, the region caudal to the foramen magnum was excluded. 
To ensure the same size, orientation, and voxel sizes, all scans were aligned by auto-
matically registering the images to a common space using rigid and affine transfor-
mations. Images were registered using the Mattes Mutual Information [20] with a gradient 
descent optimizer. In addition to registration, the scans were downsampled to allow the 
entire scan to be passed into the CNNs. After the preprocessing, each scan had a size of 
256 × 256 × 32, with a slice thickness of 5 mm. 
The voxel intensities were clipped between −20 and 120 HU and subsequently nor-
malized between minus one and one. The preprocessing was done using SimpleITK 
[21,22] and Python 2.7. 
2.4. CNN for Automatic Posterior Circulation Lesion Segmentation 
The preprocessed images were input to a CNN which consisted of three-dimensional 
convolutional kernels. The architecture of the CNN (shown in Figure A2A in the appen-
dix) was inspired by U-Net [23] and ResNet [24]. The CNN consisted of a downsampling 
path and an upsampling path. The downsampling path started with an input block, con-
sisting of a convolution with a kernel size of three and a stride of one, which was followed 
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by a max pooling layer with a pooling size of two and a stride of two. The dimensions of 
the input were 256 × 265 × 32, and the input block generated features that consisted of 
eight channels.  
Subsequent to the input block, three downsampling blocks were added, consisting of 
three 3D ResNet layers, as shown in Figure A2B in the appendix. The first two blocks were 
followed by average pooling with a stride and pooling size of two.  
The upsampling path started with a transposed convolution using a stride of two. 
Next, two upsampling blocks followed by an output layer were added. Each upsampling 
block consisted of two ResNet layers, which were followed by a transposed convolution 
with a stride of two and a kernel size of three. Each upsampling block took the featu     
res from the previous block and the corresponding downsampling block and concate-
nated them. The output block consisted of two ResNet blocks followed by a convolutional 
layer. The CNNs were implemented using Tensorflow 1.5. 
2.5. Experimental Setup 
Four different training strategies for CNNs were evaluated: A CNN was randomly 
initialized and trained on images of patients in the HERMES dataset (ACS-CNN), BASICS 
dataset (PCS-CNN), and the HERMES and BASICS datasets combined (CD-CNN). The 
ACS-CNN was used to establish the generalization ability of a CNN trained on ACS to 
PCS lesion segmentation. The PCS-CNN served as a baseline for training with limited but 
representative data. The CD-CNN was used as a benchmark if both ACS and PCS data 
were available, but no transfer learning was used. Transfer learning reused the weights 
from the trained ACS-CNN to initialize all but the last block of the CNN, and it fine-tuned 
by updating all the weights, using images from the BASICS dataset (TL-CNN).  
The CNNs used group normalization with four groups, the Leaky ReLU activation 
function, a batch size of two, and the Adam optimizer. The loss function used was the 
weighted binary cross-entropy. The initial learning rate for the ACS-CNN and CD-CNN 
was 10−3 and was decayed stepwise after 5, 10, 15, and 20 epochs to respectively, 5 × 10−4, 
2 × 10−4, 10−4, and 10−5. These networks were trained for 25 epochs. The initial learning for 
the PCS-CNN and TL-CNN was 10−5 and was decayed after 25, 50, and 75 epochs to re-
spectively, 5 × 10−6, 2 × 10−6, and 10−6. These networks were trained and fine-tuned for 100 
epochs. The weight decay was set to 10−5. 
Data augmentation was applied at training time. The images were rotated at a ran-
domly chosen angle between zero and ten degrees along the axial plane in either direction 
or were randomly flipped along the sagittal plane. 
We evaluated the performance of the ACS-CNN to check whether the model con-
verges during pre-training. The ACS dataset was split randomly into scans for training 
(85%), validation (5%), and testing (10%). For this approach, we used the entire PCS da-
taset for evaluation. Thus, we used stratified 5-fold cross-validation. Given the number of 
available PCS patients, the first four testing splits consisted of 20% and the fifth consisted 
of 22% of the data. The training splits were of equal size and consisted of 78% of the PCS 
data.  
2.6. Evaluation 
The reliability between the automatically and manually segmented volumes was 
evaluated with the intraclass correlation coefficient (ICC) including the 95% Confidence 
Interval (95%CI). The ICC was interpreted in accordance to the American Psychological 
Association [25]. Following their guidelines, an ICC < 0.4 is defined as poor, an ICC be-
tween 0.4 and 0.6 is defined as fair, an ICC between 0.6 and 0.75 is defined as good, and 
an ICC greater than 0.75 is defined as excellent. In addition, a Bland–Altman analysis was 
performed to assess the bias and limits of agreement (LoA) in volume measurements. Sta-
tistical significance between ICCs was evaluated by using Fisher’s r-to-z transformation. 
We determined whether our model accurately detected lesions independent of size. 
Thus, we calculated the ratio of the total number of correctly detected lesions and the total 
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number of lesions as determined by the ground truth in the dataset. A lesion was defined 
as detected if the percentage of overlapping voxels between the automatic and reference 
segmentations was larger than a predefined minimum. However, in case of small thresh-
olds, a non-zero overlap of automated and reference lesion segmentation could be caused 
by chance. To account for this issue, the required minimum percentage of overlapping 
voxels to count a lesion as detected was set to be either greater than zero percent or greater 
than a more conservative 20%. Next, the effect of lesion volume on the lesion detection 
rate was studied by excluding lesions of a progressively larger volume in the reference 
segmentations. This latter cutoff was set between zero and 4 mL with increments of 0.5 
mL. 
The segmentation performance of the automatic methods was evaluated by calculat-
ing the Dice coefficient as an overlap measure between the reference and the automatic 
segmentation. Normality of the distribution of the Dice coefficients was assessed before 
pairwise statistical testing by using the Shapiro–Wilk test. If the Dice coefficients were 
normally distributed, a paired t-test was used; otherwise, a Wilcoxon rank sum test was 
used. p-values were corrected for the family wise error rate using the Bonferroni correc-
tion. All statistical testing was done using the python library Pingouin, v.0.3.1 [26] 
(University of California, Berkeley, CA, USA). 
3. Results 
Baseline characteristics of the patients in BASICS and HERMES datasets were com-
pared. Patients in the HERMES dataset had a similar age to patients in the BASICS dataset. 
Diabetes (26.2% vs. 16.6%, p < 0.05) and prior stroke (19.6% vs. 11.9%, p < 0.05) occurred 
more frequently in patients in the BASICS dataset. However, atrial fibrillation (12.1% vs. 
30.8%, p < 0.01) occurred more frequently in patients in the HERMES dataset.  
The median FLV in patients with PCS was 11 (IQR: 3.4–36) mL. The ICCs for volume 
assessments for the TL-CNN, PCS-CNN, CD-CNN, and ACS-CNN were 0.88 (95% CI: 
0.83–0.92), 0.80 (95% CI: 0.72–0.86), 0.83 (95% CI: 0.76–0.88), and 0.55 (95% CI: 0.4–0.67), 
respectively. The ICC of the TL-CNN was significantly larger than the ICCs of the ACS-
CNN (p < 0.01) and PCS-CNN (p = 0.02). The ICC of the ACS-CNN was significantly 
smaller than the ICCs of the PCS-CNN (p < 0.01) and CD-CNN (p < 0.01). In addition, the 
Bland–Altman analysis for each of the CNNs resulted in biases ranging from 0.8 mL for 
the TL-CNN to 13.5 mL for the ACS-CNN. The LoAs were the smallest for the TL-CNN 
with −29 to 30 mL and largest for the ACS-CNN with −32 to 59 mL. The bias and LoAs of 
the volume measurements are shown in Figure 1 and, Table A3 in the appendix. 




Figure 1. Comparison of the automated and reference segmentation volume for the Transfer 
Learned CNN (TL-CNN), Posterior Circulation Stroke CNN (PCS-CNN), Combined Datasets 
CNN (CD-CNN), and Anterior Circulation Stroke CNN (ACS-CNN). Left column: Scatter plots 
comparing lesion volumes derived from the reference segmentations (y-axis) and from the auto-
matic segmentations determined by the CNN (x-axis). Right column: Bland–Altman plots of the 
lesion volumes. The volumes corresponding to the reference and automatic segmentations are 
shown on the x-axis and the volume difference is shown on the y-axis. 
The lesion detection rate of the TL-CNN was higher than for the other learning strat-
egies (Figure 2), which shows that the lesion detection rate increases with increasing lesion 
volume and that the lesion detection rate decreases with increasing thresholds of overlap-
ping voxels. 




Figure 2. Percentage of detected lesions (y-axis) as a function of the minimum volume requirement (x-axis) and the mini-
mum percentage of overlapping voxels for the Transfer Learned CNN (TL-CNN), Posterior Circulation Stroke CNN (PCS-
CNN), Combined Datasets CNN (CD-CNN), and Anterior Circulation Stroke CNN (ACS-CNN) (green, blue, red, and 
gray lines). For all methods, a higher lesion volume cutoff results in a higher percentage of detected lesions. The lower 
overlapping voxel requirement, the higher the percentage of detected lesions (dotted versus solid lines). 
The TL-CNN, PCS-CNN, CD-CNN, and ACS-CNN achieved a Dice coefficient of 
0.25 ± 0.08, 0.21 ± 0.06, 0.16 ± 0.06, and 0.07 ± 0.03, on the overall PCS test set, respec-
tively(Figure 3). The Dice coefficients were not normally distributed. Hence, a Wilcoxon 
rank sum test was used. Results of the Wilcoxon rank sum test are shown in Table A4. For 
the anterior circulation stroke lesions, the ACS-CNN achieved an average Dice coefficient 
of 0.60 ± 0.07. 




Figure 3. An example of automatic segmentation results obtained by the four CNNs on the PCS 
test set. From the left to the right column: the original scan, the automatic segmentation results 
from the TL-CNN, PCS-CNN, CD-CNN, and ACS-CNN are shown. The segmentation maps show 
true positives (green), false positives (blue), and false negatives (orange). The scans were plotted 
using a window center around 35, with a window width of 30. 
4. Discussion 
Our study found that transfer learning results in a high level of agreement between 
manually delineated and automatically quantified lesion volumes on the follow-up 
NCCTs of patients with a PCS. Furthermore, we found that transfer learning resulted in 
higher spatial accuracy and larger volume agreement of automatic PCS lesion segmenta-
tion compared to the other strategies. In addition, the TL-CNN models also detected a 
larger number of PCS lesions in comparison to the other strategies. Moreover, our results 
indicate that the ACS-CNN models, which were trained on only patients who suffered 
from an ACS, do not generalize to PCS lesion segmentation.  
Our study is the first to address the automated segmentation of posterior circulation 
stroke lesions on sub-acute follow-up NCCT. Previous work include anterior stroke lesion 
segmentation in a variety of imaging modalities, such as baseline CTP [27], baseline CTA 
[28], follow-up NCCT [6], and baseline and follow-up DWI [29] using multiple approaches 
and addressing various types of stroke. 
A previous study focused on developing a CNN-based method for automatic ACS 
lesion segmentation on FU-NCCT [6] with a higher spatial overlap accuracy than found 
in our study. This could be explained by the larger lesion volumes in their population 
(median FLV of 48 vs. 11 mL) and the larger dataset available for training. Furthermore, 
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beam-hardening artifacts are common in the posterior fossa on NCCT. Beam-hardening 
artifacts may obscure lesions caused by a posterior circulation stroke, making these lesions 
harder to detect than lesions caused by anterior circulation stroke. Finally, the Dice coef-
ficient is a global overlap metric, which is valuable when comparing large delineations. If 
the objects of interest are smaller, such as for the lesions in our population, the Dice coef-
ficient may be too sensitive to small errors. Therefore, the Dice coefficient must be inter-
preted in addition to other metrics, such as the lesion detection rate and the correspond-
ence in lesion volume, as expressed with the ICC between the automatically quantified 
and reference volumes, and not in isolation. The latter measure, lesion volume, is also 
clinically a more relevant measure than the spatial overlap. If we put the performance of 
our algorithms in context using the ICC, it shows that our algorithm can adequately pre-
dict FLV, which has a strong association with functional outcome in clinical practice. In 
addition, the bias and LoAs of the FLV were comparable to other studies assessing infarct 
volumes for similar problems. One study found a bias between the automatically and 
manually segmented FLV on FU-NCCT of ACS patients with subtle hypo-densities of 29 
mL with LoA of −91 to 149 mL, which are both considerably larger compared to our study 
[6]. Another study found a bias between the automatically and manually segmented FLV 
on baseline NCCT of ACS patients of 11 mL with LoA of −59 to 80 mL [30]. Our algorithm, 
which utilized transfer learning, resulted in a bias of 0.84 mL and LoA of −29 to 30 mL, 
showing that, on average, the bias in FLV is small. A weakness, as in many other studies, 
is the large LoA values in our study. Since the infarct volumes are clinically mostly used 
in prognostic models, it is unknown to what extent this patient-specific variation in FIV 
influences prognosis. However, the large LoAs suggest that patient-specific analysis still 
has to be improved before the algorithm could be applied in a clinical setting. 
Other methods for automatic ACS lesion segmentation used information from the 
contralateral hemisphere to improve segmentation accuracy [28,31]. PCS lesions can affect 
both hemispheres; hence, comparing information between the ipsilateral and its contrala-
teral hemisphere is unlikely to improve the accuracy. 
Automated stroke lesion segmentation has also been developed for chronic stroke 
lesions on T1 MRI. Chronic stroke lesions have been segmented by using a random forest 
classifier to segment lesions in the left hemisphere by using hand-crafted image features 
[32]. Another study used a deep residual network to segment lesions on images of the 
ATLAS dataset, which contains manually traced lesions on 304 T1-weighted MRI images 
[33]. Both studies achieved higher similarity scores than our method, which could be ex-
plained by the larger FLVs and higher sensitivity provided by T1-weighted MRI images. 
In previous research, transfer learning has also been successfully applied to improve 
the accuracy of various other medical image segmentation tasks. One study used CNNs 
pre-trained on eight different medical image segmentation tasks on various imaging mo-
dalities to improve automatic lung, liver, and liver tumor segmentation [34]. Unlike the 
aforementioned study, our study pre-trained on a single imaging modality and task. An-
other study pre-trained CNNs using self-supervised tasks to improve lung nodule, liver, 
and brain tumor segmentation [35]. In agreement with our study, the results of prior work 
indicate that for medical image segmentation, transfer learning can be beneficial.  
Other work using transfer learning for medical image tasks included CNNs pre-
trained on ImageNet [36] as a benchmark. These studies used transfer learning to improve 
the performance on medical image analysis tasks on 2D images. However, using 
ImageNet for transfer learning was less likely to be suitable for our study, because prior 
work has shown that ImageNet pre-training improves performance on medical image 
analysis tasks less than using a pre-trained 3D model [35]. 
This study has several limitations. First, most of the FU-NCCT scans of PCS patients 
included in this study were obtained 24 h after the onset of AIS. Creating manual reference 
segmentations of the lesions on these early FU-NCCT scans is more challenging owing to 
the subtle differences in HU values after 24 h. In addition, FLV segmentations for patients 
with PCS were performed by only one trained observer who used PC-ASPECTS scores to 
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verify the lesion location and was supervised by a radiologist (CBLMM). Since the assess-
ment was only performed by a single observer, inter-observer agreement of the reference 
standard could not be assessed. Second, this study suffered from a low number of availa-
ble PCS patients. Therefore, an even lower number of patients would be included if the 
data were divided into training, validation, and test sets. This would have lowered the 
generalizability of the results to the PCS patient population. To overcome this, five-fold 
cross-validation was used to allow all the data to be used as testing data in the analysis 
and to assess the stability of the presented results. Third, the CNNs were not accurate at 
detecting lesions with a volume smaller than 2 mL. If a patient is suspected of having 
lesions with a small volume, results from the presented algorithm should be verified by 
an expert evaluation. Transfer learning allowed the CNNs to reuse information learned 
from ACS lesion segmentation to segment lesions caused by PCS. The resulting improve-
ment in PCS lesion segmentation is likely due to the similarity between the pre-training 
and the fine-tuning tasks [37]. However, in our approach, the detection and segmentation 
of small lesions and the segmentation of lesions that are connected to cerebrospinal fluid-
filled areas is still suboptimal. Fourth, it is quite likely that the swelling due to stroke has 
caused herniation in multiple patients. In our study, we did not exclude patients based on 
herniation, also because CT cannot distinguish infarcts resulting from the acute stroke 
versus herniation. 
Deep learning is potentially valuable for automating demanding tasks in the quanti-
fication of radiological imaging. It is well-known that deep learning requires large 
amounts of data to train algorithms, which may suggest a limited applicability of deep 
learning in less common diseases. This study also shows that deep learning models that 
are trained on a more general, less specific disease may not be sufficient. Here, we pre-
sented an alternative approach based on transfer learning and showed that deep learning 
models can be pre-trained on similar diseases and fine-tuned on the specific rarer disease.  
To conclude, the presented transfer learning approach improves the automatic de-
tection and segmentation of posterior circulation stroke lesions compared to the evaluated 
commonly used training strategies. The presented automated posterior stroke lesion seg-
mentation method allows the inclusion of lesion volume as an image outcome measure 
and as a metric to predict outcome in large-scale clinical trials and potentially as a first 
step toward clinical application. 
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Appendix A 
 
Figure A1. (A) Flowchart showing the exclusion criteria used for the HERMES dataset. Exclusion criteria were: No FU-
NCCT available, which was acquired between 12 h and 2 weeks (n = 637), an intracranial region segmentation error (n = 
3), and a registration error (n = 7). In total, 1018 patients were included. These were split into a training set (n = 876), a 
validation set (n = 50), and a testing set (n = 101). (B) Flowchart showing the exclusion criteria used for the BASICS dataset. 
Exclusion criteria were: No FU-NCCT available (n = 55) or an image quality that was too low (n = 6). In total, 107 patients 
were included. These were split into five training and testing sets for the five-fold cross-validation. Patients could only 
belong to one test set. 




Figure A2. (A) 3D-Unet Architecture. The downsampling path (left) consisted of 3DResNet blocks with max pooling 
(green). The upsampling path (right) consisted of ResNet blocks followed by transposed convolutions (red). The features 
created in the downsampling path are colored blue and the features created in the upsampling path are colored yellow. 
The dotted arrows indicate the skip connections. The feature maps from the downsampling path were concatenated to the 
feature maps in the upsampling path. The input image and output probability map are colored purple. (B) 3D ResNet 
block. 
Table A1. Imaging parameters used to acquire the NCCT scans of the included patients from the BASICS trial. Imaging 
parameters were missing for two patients. 
Manufacturer Model Patients Exposure Time (mS) Exposure (mA) Tube Current kVp 
Philips iCT 256 29 1913 (IQR:1025–1913) 375(IQR: 251–490) 256 (IQR: 244–256) 100 (IQR: 100–120) 




13 2000 (IQR: 2000–2000) 340(IQR: 285–430) 172 (IQR: 143–229) 120 (IQR: 100–120) 
TOSHIBA Aquilion 11 750 (IQR: 750–750) 187(IQR: 187–225) 250 (IQR: 250–300) 120 (IQR: 120–120) 
SIEMENS Sensation 64 6 1000 (IQR: 1000–1000) 380 (IQR: 380–380) 352(IQR: 323–380) 120 (IQR: 120–120) 
Philips Brilliance 64 5 1678 (IQR: 1000–1678) 351(IQR:250–351) 209(IQR: 200–209) 120 (IQR: 120–120) 




4 1000 (IQR: 1000–1000) 250(IQR: 233–290) 138 (IQR: 129–155) 120 (IQR: 115–120) 
Philips IQon—Spectral CT 4 1117 (IQR: 1117–1117) 200(IQR: 200–200) 179 (IQR: 179–179) 120 (IQR: 120–120) 
Other Various 12 1000 (IQR: 1000–1000) 260 (IQR: 158–353) 260 (IQR: 220–325) 120 (IQR: 120–120) 
Table A2. Lesion location in the posterior fossa, which was scored manually by using the PC-AS-
PECTS. 
Lesion Location Count/Total 
No lesion 15/107 
Left thalamus 33/107 
Left cerebellum 40/107 
Left PCA territory 19/107 
Right thalamus 26/107 
Right cerebellum 40/107 
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Table A3. The ICC, Dice coefficients, bias, and limits of agreement between the automatically 
quantified and manually segmented volumes, respectively for the Transfer Learned (TL-CNN), 
Anterior Circulation Stroke (ACS-CNN), Combined Dataset (CD-CNN), and Posterior Circulation 
Stroke (PCS-CNN) Convolutional Neural Networks, tested on the PCS test set. 
Method ICC Dice Bias Limits of Agreement 
TL-CNN 0.88 (95% CI: 0.83–0.92) 0.25 ± 0.07 0.84 mL −28.7 to 30.4 mL 
PCS-CNN 0.80 (95% CI: 0.72–0.86) 0.21 ± 0.06 3.8 mL −31.9 to 39.4 mL  
CD-CNN 0.83 (95% CI: 0.76–0.88) 0.16 ± 0.06 6.4 mL −27.3 to 40.2 mL  
ACS-CNN 0.55 (95% CI: 0.4–0.67) 0.07 ± 0.03 13.5 mL −32.2 to 59.1 mL  
Table A4. Wilcoxon rank sum test on pairwise differences between the Dice coefficient and the 
bias of the volume differences. The W-statistic and p-value are shown in this table. The TL-CNN 
produced a significantly greater Dice coefficient than the other methods. The PCS-CNN produced 
a significantly greater Dice coefficient than the CD-CNN and ACS-CNN, and the CD-CNN pro-
duced a significantly greater Dice coefficient than the ACS-CNN. The TL-CNN produced a signifi-
cantly smaller bias than the CD-CNN and ACS-CNN, the PCS-CNN produced a significantly 
smaller bias than the CD-CNN and ACS-CNN, and finally, the CD-CNN produced a significantly 
smaller bias than the ACS-CNN. 
Method 1 Method 2 Dice Coefficient Bias 
  W p-Value W p-Value 
TL-CNN PCS-CNN 766 <0.05 2205 0.28 
TL-CNN CD-CNN 216 <0.01 1018 <0.01 
TL-CNN ACS-CNN 62 <0.01 938 <0.01 
PCS-CNN CD-CNN 535 <0.01 1958 <0.05 
PCS-CNN ACS-CNN 114 <0.01 1350 <0.01 
CD-CNN ACS-CNN 88 <0.01 1443 <0.01 
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